CohBar Inc , a preclinical stage biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat age-related diseases, announced...
Read moreVifor Pharma, a company of the Galenica Group, and ChemoCentryx, Inc. announced that Vifor Pharma has gained rights to commercialize...
Read moreEli Lilly and Company and Incyte Corporation announced that the EC has granted marketing authorisation for Olumiant® (baricitinib) 4 mg...
Read moreJazz Pharm announced that the first patient has been enrolled in a Phase 2 clinical study evaluating JZP-110 , a...
Read moreNeuraltus Pharmaceuticals announced the confirmatory Phase 2 study of the Company’s lead investigational treatment NP001 for amyotrophic lateral sclerosis (ALS,...
Read moreAllergan plc , a global leader in eye care for nearly 70 years, announces a bold commitment to fight preventable...
Read moreArven Pharmaceuticals, a Toksoz Group Company, has selected GE Healthcare’s FlexFactory manufacturing platform to expand production capacity at its facility...
Read moreZimmer Biomet Holdings Inc , a global leader in musculoskeletal healthcare announced that the U.S. FDA approved an expanded 26-week...
Read moreNeuroVive Pharmaceutical AB , a company in mitochondrial medicine announced that research resources and activities of the Taiwan-based subsidiary redirected...
Read moreJitsubo Co., Ltd. announced that it has executed the joint development and license agreement with a Japanese pharmaceutical company (undisclosed)...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.